Dermatological drugs market has been growing over the last decade. A combination of significant new market launches and corporate activities has changed the outlook of the pharmaceutical industry towards this market. The dermatological drugs market in 2018 was reported to be US$ 26.23 bn. This analysis of the market shows Humira, Stelara, Enbrel, Remicade, Otezla and Cosentyx among the top dermatological drugs driving the market at present.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
By ordering and reading our brand new report today you stay better informed and ready to act.
Assessment of the leading companies in the global dermatological drugs market. The list below shows some of the companies that are discussed in the report:
- Abbvie Inc.
- Allergan plc
- Almirall S.A.
- Concert Pharmaceuticals
- Eli Lilly and Company
- GlaxoSmithkline plc (GSK)
- Johnson & Johnson (J&J)
- Leo Pharma A/S
- Lupin Ltd
- Mayne Pharma
- Other companies
This report discusses financial outlook, product portfolio and strategic developments.